263 related articles for article (PubMed ID: 28249651)
21. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
[TBL] [Abstract][Full Text] [Related]
22. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
[TBL] [Abstract][Full Text] [Related]
24. Risk profile for osteoradionecrosis of the mandible in the IMRT era.
Studer G; Bredell M; Studer S; Huber G; Glanzmann C
Strahlenther Onkol; 2016 Jan; 192(1):32-9. PubMed ID: 26265308
[TBL] [Abstract][Full Text] [Related]
25. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
[TBL] [Abstract][Full Text] [Related]
26. How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study.
Ursino S; Seccia V; Cocuzza P; Ferrazza P; Briganti T; Matteucci F; Fatigante L; Giusti P; Grosso M; Locantore L; Morganti R; Nacci A; Sellari Franceschini S; Paiar F; Caramella D; Fattori B
Acta Otorhinolaryngol Ital; 2016 Jun; 36(3):174-84. PubMed ID: 27070541
[TBL] [Abstract][Full Text] [Related]
27. Systematic dosimetric evaluation of risk of osteoradionecrosis (DERO): First results of dose reporting for preventing teeth osteoradionecrosis after head and neck irradiation.
Delpon G; Renouf M; Langé M; Blery P; Dupas C; Longis J; Thariat J; Doré M
Cancer Radiother; 2023 Apr; 27(2):103-108. PubMed ID: 36739196
[TBL] [Abstract][Full Text] [Related]
28. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
Grant SR; Hutcheson KA; Ye R; Garden AS; Morrison WH; Rosenthal DI; Brandon Gunn G; Fuller CD; Phan J; Reddy JP; Moreno AC; Lewin JS; Sturgis EM; Ferrarotto R; Frank SJ
Radiother Oncol; 2020 Jul; 148():133-139. PubMed ID: 32361662
[TBL] [Abstract][Full Text] [Related]
29. Osteocutaneous free tissue transplantation for mandibular osteoradionecrosis.
Chandarana SP; Chanowski EJ; Casper KA; Wolf GT; Bradford CR; Worden FP; Eisbruch A; Chepeha DB
J Reconstr Microsurg; 2013 Jan; 29(1):5-14. PubMed ID: 23093466
[TBL] [Abstract][Full Text] [Related]
30. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
31. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
32. Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation.
Kirsh E; Naunheim M; Holman A; Kammer R; Varvares M; Goldsmith T
Laryngoscope; 2019 Sep; 129(9):2059-2064. PubMed ID: 30582151
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
[TBL] [Abstract][Full Text] [Related]
34. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer.
Dohopolski MJ; Diao K; Hutcheson KA; Akhave NS; Goepfert RP; He W; Lei XJ; Peterson SK; Shen Y; Sumer BD; Smith BD; Sher DJ
JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):697-707. PubMed ID: 37382943
[TBL] [Abstract][Full Text] [Related]
35. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Lai SY; Fuller CD; Lewin JS; Piller LB; Hutcheson KA
Head Neck; 2019 Nov; 41(11):3880-3894. PubMed ID: 31441572
[TBL] [Abstract][Full Text] [Related]
36. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.
Gomez DR; Estilo CL; Wolden SL; Zelefsky MJ; Kraus DH; Wong RJ; Shaha AR; Shah JP; Mechalakos JG; Lee NY
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e207-13. PubMed ID: 21570202
[TBL] [Abstract][Full Text] [Related]
37. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
Goepfert RP; Lewin JS; Barrow MP; Gunn GB; Fuller CD; Beadle BM; Garden AS; Rosenthal DI; Kies MS; Papadimitrakopoulou V; Lai SY; Gross ND; Schwartz DL; Hutcheson KA
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):700-708. PubMed ID: 27485284
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
[TBL] [Abstract][Full Text] [Related]
39. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.
Sio TT; Lin HK; Shi Q; Gunn GB; Cleeland CS; Lee JJ; Hernandez M; Blanchard P; Thaker NG; Phan J; Rosenthal DI; Garden AS; Morrison WH; Fuller CD; Mendoza TR; Mohan R; Wang XS; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1107-14. PubMed ID: 27354125
[TBL] [Abstract][Full Text] [Related]
40. Is the Risk to Develop Osteoradionecrosis of the Jaws Following IMRT for Head and Neck Cancer Related to Co-Factors?
Rosenfeld E; Eid B; Masri D; Popovtzer A; Mizrachi A; Chaushu G
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34064551
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
